Report calls for needle & syringe programs in prisons to address hepatitis C in Australia

AIVL has released a new report, looking at the needs of people living with Hepatitis C after leaving custodial settings in Australia.  The report contains a series of recommendations aimed at addressing the spread of blood borne viruses (BBVs) in the Australian community more broadly, including trialling of a Needle and Syringe Program (NSP) in prison and increased focus on transitional arrangements for people returning to the community.

Read More

Action required on falling treatment rates

Australia will not achieve the goal of eradicating hepatitis C without further action to ensure patients are identified and treated.

Speaking with PharmaDispatch following her appointment as president of Hepatitis Australia, Felicity McNeill PSM, said so much positive work has been done, with thousands of people cured, but all stakeholders must come together to address the fact treatment rates are in decline.

Read More